VALN · Valneva SE ADR
United States · RS rating 48 · As of 2026-11-03
| Price | 5.51 USD |
|---|---|
| 1-day change | +3.6% |
| RS rating (overall / 1M / 3M / 12M) | 48 / 44 / 76 / 26 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 22 / 12 / 22 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +62.1% |
| Distance from 52-week high | +54.0% |
| Market cap (USD) | $463.1M |